Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-02-19 @ 3:13 AM
Study NCT ID:
NCT00674557
Status:
TERMINATED
Last Update Posted:
2013-07-10
First Post:
2008-05-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer
Sponsor:
Cancer Research UK
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent breast cancer | View |
| None | stage IIIA breast cancer | View |
| None | stage IIIB breast cancer | View |
| None | stage IIIC breast cancer | View |
| None | stage IV breast cancer | View |
| None | HER2-negative breast cancer | View |
| None | estrogen receptor-positive breast cancer | View |
| None | progesterone receptor-positive breast cancer | View |